Does OLAPARIB Cause Dermatitis? 8 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Dermatitis have been filed in association with OLAPARIB (Lynparza). This represents 0.0% of all adverse event reports for OLAPARIB.
8
Reports of Dermatitis with OLAPARIB
0.0%
of all OLAPARIB reports
1
Deaths
1
Hospitalizations
How Dangerous Is Dermatitis From OLAPARIB?
Of the 8 reports, 1 (12.5%) resulted in death, 1 (12.5%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Dermatitis Listed in the Official Label?
Yes, Dermatitis is listed as a known adverse reaction in the official FDA drug label for OLAPARIB.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Dermatitis?
DUPILUMAB (3,823)
ADAPALENE (2,088)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (1,615)
ADALIMUMAB (530)
METHOTREXATE (452)
ETANERCEPT (317)
SECUKINUMAB (294)
INFLIXIMAB (268)
NIVOLUMAB (251)
DENOSUMAB (246)
Which OLAPARIB Alternatives Have Lower Dermatitis Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL